TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/28/21 19:31 | 4/26/21 | RVMD | Revolution Medicines, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Svennilson Peter | CA | D | S.m | -3,269 | 42.79 | 0 | -76 | -2 | 3,166 | I | |||||||||||||||
4/12/21 17:41 | 4/8/21 | RVMD | Revolution Medicines, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Svennilson Peter | CA | D | S.m | -3,154 | 44.46 | 0 | -71 | -2 | 3,206 | I | |||||||||||||||
4/7/21 18:23 | 4/5/21 | RVMD | Revolution Medicines, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Svennilson Peter | CA | D | S.m | -4,023 | 46.96 | 0 | -86 | -3 | 3,244 | I | |||||||||||||||
11/18/20 18:58 | 11/16/20 | RVMD | Revolution Medicines, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Svennilson Peter | CA | DT | S | -73,788 | 36.40 | 0 | -2,027 | -35 | 3,806 | I | |||||||||||||||
9/22/20 19:51 | 9/22/20 | RAPT | Rapt Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Svennilson Peter | CA | DT | S | -18,757 | 30.85 | 0 | -608 | -10 | 5,630 | I | |||||||||||||||
8/19/20 17:41 | 8/17/20 | RAPT | Rapt Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Svennilson Peter | CA | DT | S | -12,254 | 22.75 | 0 | -539 | -8 | 6,238 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |